Shares of aerospace components manufacturer Triumph Group spiked 34% yesterday, Monday, February 3, and hit a nearly four-year high. The trigger was an announcement that the company would be acquired at a 38% premium by affiliates of private equity giants Berkshire Partners and Warburg Pincus. Noble Capital Markets believes the…
Shares of several small-cap suppliers of avocados took a tumble yesterday, Monday, February 3, following the announcement by President Donald Trump of new tariffs on Mexico, Canada, and China. However, the losses eased later in the day after the U.S. and Mexico agreed to a truce for a month. Note…
The Motley Fool has spotlighted two reasons to buy shares of EVgo, a smaller company that builds charging stations for electric vehicles (EVs). The U.S. EV market is growing, and even the new administration of President Donald Trump is unlikely to stifle this growth. Moreover, the company holds a competitive…
Shares of Puerto Rican consulting firm Pharma-Bio Serv have the potential to rise 150% from current levels, according to Zacks Small-Cap Research (Zacks SCR). While the company had a bumpy 2024, its management is confident negative trends will reverse in 2025. Details Pharma-Bio Serv helps pharmaceutical companies to comply with…
Chip Skinner, who manages the Royce Smaller-Companies Growth Fund, has spotlighted ACV Auctions and Cantaloupe as two “high-confidence” holdings. The fund is part of Royce Investment Partners, founded by Wall Street legend Chuck Royce, and invests in companies that, in the words of Skinner, “look poised for multi-year periods of…
Piper Sandler expects the small- and mid-cap Russell 2000 index to outgain the large-cap S&P 500 in 2025. The investment bank believes that stocks of smaller companies offer investors the “most compelling opportunities,” as the underlying businesses are bolstered by a robust labor market, rising productivity, and an overall strong…
Quotes on protective apparel manufacturer Lakeland Industries jumped almost 5% yesterday, Tuesday, January 28, after the company announced a contract with a local government procurement service in the U.S. with more than 9,000 buyers. Details Lakeland stock spiked almost 5% on the Nasdaq to $24.25 per share yesterday, before extending…
Goldman Sachs values the small-cap biotech company Vera Therapeutics at $58.00 per share, more than 60% above the current market price, as Vera’s drug candidate for autoimmune kidney diseases has shown promising results in clinical trials and is likely to hit the market next year. Details Goldman Sachs analyst Paul…
Yesterday, Monday, January 27, quotes on the small-cap oil and gas producer Diversified Energy rose 4% on the New York Stock Exchange after the company announced it had entered into an agreement to acquire peer Maverick Natural Resources for about $1.28 billion. Diversified expects the deal to nearly double its…
Shares of Canadian diamond miner Diamcor Mining have skyrocketed 300% in Frankfurt today, Tuesday, January 28. Yesterday, Diamcor surged 25% in Toronto and 65% in the U.S. (where it trades over the counter). The driver was news that Diamcor had reached a preliminary agreement with a “well-established Dubai based manufacturer…
Insider Monkey believes that now might be the best time to buy shares of smoking cessation therapy maker Achieve Life Sciences, as the stock is trading near one-year lows. That is despite the fact that the company has recently completed clinical trials for its nicotine addiction treatment and may now…
The Motley Fool warns investors against rushing into shares of Planet Labs, which has a market capitalization of $1.6 billion on the New York Stock Exchange. While the company’s strong financial performance, combined with voiced interest in space exploration by Donald Trump, has buoyed the stock, the investing advice firm…
Noble Capital Markets has identified three key factors that should buoy small-cap stocks moving forward. While the broader market reacts to macroeconomic developments like tariffs and trade policy, the small- and micro-cap space stands apart as a unique opportunity for investors, in the investment bank’s view. Recently, the Russell 2000…
In 2025, makers of drugs for Alzheimer’s disease are poised to see more interest from investors, Bloomberg reports. The number of Alzheimer’s cases is growing worldwide, and more than 160 clinical trials for Alzheimer’s treatments are currently underway. What are the most promising small caps in this niche? Market outlook…
Shares of Lakeland Industries, a manufacturer of protective clothing, slid almost 11% on Thursday, January 23, following the company’s announcement of the pricing for a planned secondary offering. It will sell 1.82 million new shares to investors at $22 apiece — the lowest price for its shares since late November.…
Ensysce Biosciences has upside of more than 250%, based on the $29.50 per share valuation of Zacks Small-Cap Research (Zacks SCR). The company is developing treatments for severe pain relief that have the power of opioids but do not carry the risk of abuse. Its products could help to put…
Shares of protective clothing manufacturer Lakeland Industries plunged almost 15% after the closing bell yesterday, Wednesday, January 22, before declining even more in premarket trading today. This came after the company announced a proposed stock offering, citing the need for cash to pay down debt accrued during an M&A spree.…
Shares of small-cap space-as-a-service company Sidus Space surged 22% yesterday, Tuesday, January 21. Other space names also rose. Wall Street analysts attribute the gains to growing enthusiasm around the sector following the return to the White House of Donald Trump, who stated during his inauguration address that the U.S. would…
Quotes on Inuvo, a small-cap provider of AI-powered marketing technology, soared more than 19% yesterday, Tuesday, January 21, after the company reported 26% year-over-year growth in preliminary revenue for the fourth quarter of 2024 to a record $26 million. Details Yesterday, Inuvo stock jumped more than 19% on the New…
Shares of Canadian small-cap KITS Eyecare, which makes and retails eyewear and contact lenses, climbed nearly 5% on the Toronto Stock Exchange on Monday, January 20. The driver was a reported 42% higher top line in the fourth quarter, combined with a record adjusted EBITDA margin. Details On Monday, KITS…
23andMe, which specializes in DNA genetic testing, is exploring a possible sale of its telehealth business, Lemonaid Health, reports Business Insider. Investors have reacted positively to the news, prompting the stock to jump more than 7% in premarket trading today, Tuesday, January 21. Details 23andMe is considering selling Lemonaid Health,…
The small- and mid-cap-tracking Russell 2000 index has fallen nearly 5% since November 6, when Donald Trump won the U.S. presidential election. By comparison, the large-cap S&P 500 index gained 1% in the same period. While Trump’s policies are generally seen as helpful for small businesses, the prospect of higher…
The investment bank Goldman Sachs has raised its target price for the smaller biotech company MoonLake Immunotherapeutics by 32% to $82 per share, double the closing price on Friday, January 17. Promising results from studies of MoonLake’s drug for skin inflammation led Goldman Sachs to believe that it could become…
According to the World Health Organization, one in five people worldwide develops some form of cancer in their lifetime. While certain cancers respond well to treatment, others manage to “shield” themselves from targeted therapies. The micro-cap company MAIA Biotechnology is developing a drug to “trick” cancer cells, infiltrate them, and…
